6CM
683 Capital Management Portfolio holdings
AUM
$986M
This Quarter Return
+7.22%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$1.02B
AUM Growth
+$1.02B
(+3.5%)
Cap. Flow
+$27.5M
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
250
New
110
Increased
34
Reduced
29
Closed
29
Top Buys
| 1 |
Western Digital
WDC
|
$26.2M |
| 2 |
HES
Hess
HES
|
$14.3M |
| 3 |
GXO Logistics
GXO
|
$13.1M |
| 4 |
AMTM
Amentum Holdings, Inc.
AMTM
|
$8.94M |
| 5 |
ASML
ASML
|
$7.38M |
Top Sells
| 1 |
SharkNinja
SN
|
$19.6M |
| 2 |
BorgWarner
BWA
|
$16.7M |
| 3 |
TG Therapeutics
TGTX
|
$13.2M |
| 4 |
Hilton Grand Vacations
HGV
|
$10.7M |
| 5 |
IRS
IRSA Inversiones y Representaciones
IRS
|
$10M |
Sector Composition
| 1 | Healthcare | 31.96% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Financials | 9.47% |
| 4 | Industrials | 6.26% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Viking Therapeutics
VKTX
$3.04B
| $11.3M | 0.7% |
280,000
-40,000
| -13% | -$1.61M |
|
|
CRESY
27
Cresud
CRESY
$591M
| $11.2M | 0.69% |
885,000
+44,000
| +5% | +$556K |
|
|
28
ASML
ASML
$288B
| $10.8M | 0.67% |
15,650
+10,650
| +213% | +$7.38M |
|
29
Iovance Biotherapeutics
IOVA
$792M
| $10.5M | 0.65% |
1,416,014
+16,014
| +1% | +$119K |
|
30
Howard Hughes
HHH
$4.5B
| $10.4M | 0.64% |
135,000
| – | – |
|
31
Harmony Biosciences
HRMY
$2.14B
| $10.3M | 0.64% |
300,000
| – | – |
|
32
Zevra Therapeutics
ZVRA
$510M
| $10.2M | 0.63% |
1,225,834
+834
| +0.1% | +$6.96K |
|
33
Caesars Entertainment
CZR
$5.21B
| $10.1M | 0.63% |
301,900
+51,900
| +21% | +$1.73M |
|
|
IRS.WS
34
IRSA Inversiones y Representaciones S.A. Warrants to purchase Common Shares
IRS.WS
$114M
| $9.31M | 0.58% |
5,086,061
+336,061
| +7% | +$615K |
|
35
Pinduoduo
PDD
$176B
| $9.21M | 0.57% |
95,000
+6,000
| +7% | +$582K |
|
|
AMTM
36
Amentum Holdings, Inc.
AMTM
$6.02B
| $8.94M | 0.55% |
+425,000
| New | +$8.94M |
|
37
KNOT Offshore Partners
KNOP
$289M
| $8.77M | 0.54% |
1,610,000
+39,800
| +3% | +$217K |
|
38
Western Alliance Bancorporation
WAL
$9.84B
| $8.35M | 0.52% |
100,000
| – | – |
|
39
Phathom Pharmaceuticals
PHAT
$842M
| $8.32M | 0.52% |
1,025,000
+15,000
| +1% | +$122K |
|
40
Noble Corp
NE
$4.54B
| $8.23M | 0.51% |
262,118
+95,000
| +57% | +$2.98M |
|
41
Ryder
R
$7.56B
| $7.33M | 0.45% |
46,752
-43,248
| -48% | -$6.78M |
|
42
Amylyx Pharmaceuticals
AMLX
$869M
| $7.3M | 0.45% |
1,930,000
-70,000
| -4% | -$265K |
|
|
ITOS
43
DELISTED
iTeos Therapeutics
ITOS
| $7.05M | 0.44% |
918,117
-652,171
| -42% | -$5.01M |
|
44
Gossamer Bio
GOSS
$582M
| $6.31M | 0.39% |
6,975,000
+1,175,000
| +20% | +$1.06M |
|
|
ARMN
45
Aris Mining
ARMN
$1.83B
| $6.31M | 0.39% |
1,798,900
-51,100
| -3% | -$179K |
|
|
IRS
46
IRSA Inversiones y Representaciones
IRS
$1.06B
| $5.97M | 0.37% |
400,000
-670,000
| -63% | -$10M |
|
47
Adecoagro
AGRO
$828M
| $5.66M | 0.35% |
600,000
+35,000
| +6% | +$330K |
|
|
48
BorgWarner
BWA
$9.28B
| $5.56M | 0.34% |
175,000
-525,000
| -75% | -$16.7M |
|
49
Novo Nordisk
NVO
$252B
| $5.16M | 0.32% |
+60,000
| New | +$5.16M |
|
50
InflaRx
IFRX
$118M
| $5.11M | 0.32% |
2,070,000
| – | – |
|